Grow Therapy

Liquid AI

Grow Therapy

Two-sided marketplace for mental health. Therapists join Grow Therapy's network and the company handles insurance credentialing, claims billing, scheduling, and compliance.

In return, Grow Therapy takes a percentage of each session's insurance reimbursement. Patients search Grow Therapy's directory to find in-network therapists by specialty, insurance plan, and availability.

The therapist gets to focus on therapy. The patient gets affordable care.

Grow Therapy gets a cut for handling the business side. Everyone wins except the old credentialing companies that charged therapists thousands of dollars to do what Grow Therapy does for free.

Liquid AI

Liquid AI builds foundation models, the big general-purpose brains that power chatbots and other AI tools. The difference is efficiency.

Their models, called Liquid Foundation Models, are designed to do more with far less memory and computing power. Companies pay to use them, either through a cloud API or by running the models on their own machines.

That second option matters. A bank or a hospital often cannot send private data to someone else's server.

Liquid AI lets them keep the model in-house. The pitch to a customer is basically this.

You get strong AI without renting a mountain of expensive chips.

Grow Therapy

Jake Cooper was working in healthcare operations when he saw the same problem from both sides. Patients couldn't find therapists who accepted their insurance.

Therapists wanted to accept insurance but the credentialing process took 6 to 12 months and the billing was a bureaucratic disaster. Most therapists just went cash-pay to avoid the headache, which meant only people who could afford $200 a session got care.

Cooper started Grow Therapy in 2020 to solve the plumbing problem. Not the clinical side — the administrative infrastructure that makes it possible for a therapist to see an insured patient without losing their mind.

He launched right as the pandemic made therapy demand explode and supply couldn't keep up.

Liquid AI

Liquid AI is a spinout from MIT's Computer Science and Artificial Intelligence Laboratory, better known as CSAIL. The core science came from Ramin Hasani, who spent his PhD studying the nervous system of a tiny worm called C.

elegans. That worm has just 302 neurons and still manages to move, hunt, and react to its world.

Hasani and his collaborators asked a simple question. What if you built an AI that worked more like those neurons and less like a giant static network?

The answer was the liquid neural network, a model whose internal wiring keeps adjusting even after training is done. The team incorporated the company in 2023.

Daniela Rus, who runs CSAIL and is one of the most respected robotics researchers alive, came on as a co-founder. So did Mathias Lechner and Alexander Amini, both longtime research partners of Hasani.

Grow Therapy

Supply-side acquisition — recruit therapists by solving their biggest pain point (insurance credentialing) for free. Once therapists are in-network through Grow Therapy, patients find them through the directory.

The company expanded insurance partnerships aggressively, getting in-network with Aetna, Cigna, UnitedHealthcare, Anthem, and dozens of regional plans. State-by-state expansion tracking licensing requirements.

Content marketing targeting therapists frustrated with private practice admin. Referral loops from satisfied therapists bringing colleagues onto the platform.

Liquid AI

The growth angle is size, or the lack of it. Most frontier models are so heavy they only run in data centers.

Liquid AI aims for models light enough to run on a phone, a car, or a factory robot. That opens doors the giants cannot easily reach.

The AMD partnership pushes the same idea. AMD makes chips, and it wants efficient models that show off its hardware.

So AMD led the Series A and became both an investor and a distribution partner. Liquid AI also releases open models to researchers, which builds a following before the sales team ever makes a call.

Grow Therapy

Insurance reimbursement rates for therapy are low and getting lower in some states. Grow Therapy's margin depends on volume because per-session economics are thin.

Keeping therapists on the platform once they're credentialed is a retention challenge — some therapists use Grow Therapy to get credentialed, then leave to handle billing themselves. Competition from Headway, Alma, and others doing similar things means the race to sign up therapists is intense.

Quality control across 10,000+ providers is a real concern. And the fundamental tension remains: insurance companies want to pay less per session, therapists need to earn enough to survive, and Grow Therapy sits in the middle trying to make both sides happy.

Liquid AI

The honest problem is Goliath. OpenAI, Google, Anthropic, and Meta have raised tens of billions of dollars between them.

Liquid AI has raised under $300 million. The transformer architecture those giants use is battle-tested and improving fast.

Liquid AI has to prove its different approach not only works but keeps working as models get bigger. Betting against the most successful design in AI history is bold.

It is also the kind of bet that ends in either a great acquisition or a quiet shutdown, with not much room in between.

Grow Therapy

Insurance credentialing — gets therapists paneled with major insurers in weeks instead of months. Automated billing and claims processing that eliminates the denied-claim nightmare.

A patient-facing directory with filters for insurance, specialty, location, and availability. Practice management tools including scheduling, intake forms, and session notes.

Telehealth platform built in so therapists don't need separate video software. Group practice support for therapists who want to scale beyond solo practice.

Liquid AI

The main products are the Liquid Foundation Models, a family that ships in several sizes so a customer can pick the smallest one that does the job. The second generation, LFM2, arrived in 2025, including LFM2-VL vision-language models built for phones, laptops, wearables and embedded chips.

The company has leaned hard into on-device AI rather than the cloud. The focus is always the same.

Match the quality of a much larger model while using a fraction of the memory and power.

Grow Therapy

Investors include Sequoia Capital, TCV, Signalfire, and SVB Capital. Series C in 2023 valued the company at over $1 billion.

Liquid AI

It started with a $37.5 million two-stage seed in December 2023 at a $303 million valuation, from OSS Capital, PagsGroup, Automattic (the company behind WordPress), Samsung Next and others. Angels included GitHub co-founder Tom Preston-Werner, Shopify's Tobi Lütke and Red Hat co-founder Bob Young.

Then AMD Ventures led the $250 million Series A in December 2024, which is unusual because AMD is a chipmaker, not a typical venture fund. That backing gave Liquid AI both money and a hardware ally.

When a major chip company writes the lead check on an efficiency-focused model maker, it signals a bet that the future of AI is not just bigger, it is leaner.